title: A murine model of ulcerative colitis: induced with sinusitis-derived superantigen and food allergen.
abstract: BACKGROUND
  The etiology of ulcerative colitis (UC) is to be understood. The basic pathological feature of UC is intestinal chronic inflammation. Superantigen, such as Staphylococcus enterotoxin B (SEB), is reported to compromise intestinal barrier function by increasing epithelial permeability and initiate inflammation in the intestinal mucosa. Inasmuch as anatomic position of the sinus, chronic sinusitis-derived SEB may follow the secretion and to be swallowed down to the gastrointestinal tract and induce lesions to the intestinal mucosa.
  
  
  METHODS
  Sinus wash fluid (SWF, containing SEB) was collected from a group of patients with both chronic sinusitis (CS) and UC. A group of mice were sensitized to ovalbumin (OVA) in the presence of SWF. The sensitized mice were challenged with the specific antigen OVA. The inflammatory status of the colonic tissue was determined with histology, serology and electron microscopy. Using horseradish peroxidase (HRP) as a tracer, another group of mice was stimulated with SWF for 2 hours. The HRP activity was detected in the colonic tissue with enzymatic approaches and electron microscopy.
  
  
  RESULTS
  Epithelial hyperpermeability in colonic epithelium was induced by stimulating with SWF. The HRP activity in the colonic mucosa was almost 11 times more in the SWF treated group (3.2 +/- 0.6 microg/g tissue) than the control group (0.3 +/- 0.1 microg/g tissue). Mice were sensitized using a mixture of SWF and OVA (serum OVA-specific IgE was detected with a highest titer as 1:64). Challenge with OVA induced extensive inflammation in the colonic mucosa by showing (1) marked degranulation in mast cells (MC, 46.3 +/- 4.5%) and eosinophils (Eo, 55.7 +/- 4.2%); (2) inflammatory cell infiltration (MC = 145.2 +/- 11.4; Eo = 215.8 +/- 12.5; mononuclear cell = 258.4 +/- 15.3/mm2 tissue); (3) increased MPO activity (12.9 +/- 3.2 U/g tissue) and inflammatory scores (1.8 +/- 0.3); (4) mucosal surface ulcers; (5) edema in the lamina propria; (6) bacterial translocation and abscess formation in the subepithelial region.
  
  
  CONCLUSIONS
  Introducing Sinusitis-derived SEB-containing SWF to the gastrointestinal tract compromised colonic mucosal barrier function increasing epithelial permeability to luminal macromolecular protein in mice. The SWF facilitated colonic mucosal sensitization to luminal antigen. Multiple challenging the sensitized colonic mucosa with specific antigen OVA induced inflammation, induced a condition similar to human ulcerative colitis.
authors.affiliation: Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. yangp@mcmaster.ca
authors.forename: Ping-Chang
authors.initials: PC
authors.lastname: Yang
authors.forename: Chang-Sheng
authors.initials: CS
authors.lastname: Wang
authors.forename: Zi-Yuan
authors.initials: ZY
authors.lastname: An
mesh_terms: D000328:Adult; D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology*; D002908:Chronic Disease; D003093:Colitis, Ulcerative / Q000276:immunology*; D003106:Colon / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D003967:Diarrhea / Q000276:immunology; D004195:Disease Models, Animal; D004768:Enterotoxins / Q000276:immunology*; D004804:Eosinophils / Q000473:pathology; D005260:Female; D006735:Horseradish Peroxidase / Q000493:pharmacokinetics; D006801:Humans; D007114:Immunization; D007073:Immunoglobulin E / Q000378:metabolism; D007413:Intestinal Mucosa / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D008297:Male; D008407:Mast Cells / Q000473:pathology; D051379:Mice; D008875:Middle Aged; D010047:Ovalbumin / Q000276:immunology*; D010256:Paranasal Sinuses / Q000378:metabolism; D010539:Permeability; D012852:Sinusitis / Q000276:immunology* / Q000378:metabolism; D018089:Superantigens / Q000276:immunology*; D007507:Therapeutic Irrigation
chemical_list: D000942:Antigens, Bacterial; D004768:Enterotoxins; D018089:Superantigens; D007073:Immunoglobulin E; C031818:enterotoxin B, staphylococcal; D010047:Ovalbumin; D006735:Horseradish Peroxidase
references.citation: Int Arch Allergy Immunol. 2004 Mar;133(3):261-6
references.pmid: 14976395
references.citation: Curr Opin Infect Dis. 2003 Apr;16(2):129-34
references.pmid: 12734445
references.citation: Int J Med Microbiol. 2004 Apr;293(7-8):529-37
references.pmid: 15149028
references.citation: Gastroenterology. 2004 May;126(6):1504-17
references.pmid: 15168363
references.citation: Gastroenterol Clin North Am. 2004 Jun;33(2):335-45, x
references.pmid: 15177542
references.citation: Rev Gastroenterol Disord. 2004 Spring;4(2):66-85
references.pmid: 15184826
references.citation: Gastroenterology. 2004 Jun;126(7):1897-9
references.pmid: 15188186
references.citation: Biochim Biophys Acta. 2004 Jul 6;1673(1-2):66-74
references.pmid: 15238250
references.citation: J Invest Dermatol. 1982 Mar;78(3):206-9
references.pmid: 6276474
references.citation: Am J Physiol. 1982 Jun;242(6):G558-64
references.pmid: 7091328
references.citation: J Immunol. 1990 Feb 1;144(3):892-901
references.pmid: 2136903
references.citation: Adv Immunol. 1991;50:1-53
references.pmid: 1835267
references.citation: Eur J Immunol. 1992 Apr;22(4):1007-11
references.pmid: 1551401
references.citation: J Infect Dis. 1993 May;167(5):997-1002
references.pmid: 8486972
references.citation: Am J Respir Crit Care Med. 1995 Jan;151(1):184-93
references.pmid: 7812551
references.citation: Gut. 1995 Jan;36(1):1-4
references.pmid: 7534251
references.citation: J Exp Med. 1996 Apr 1;183(4):1437-46
references.pmid: 8666902
references.citation: J Immunol. 1996 Aug 1;157(3):1261-70
references.pmid: 8757634
references.citation: Am J Rhinol. 2003 Mar-Apr;17(2):87-90
references.pmid: 12751702
references.citation: Anat Rec A Discov Mol Cell Evol Biol. 2003 Sep;274(1):778-84
references.pmid: 12923888
references.citation: Curr Drug Targets Inflamm Allergy. 2003 Dec;2(4):303-12
references.pmid: 14561149
references.citation: J Allergy Clin Immunol. 2003 Nov;112(5):981-7
references.pmid: 14610492
references.citation: Gastroenterology. 2003 Dec;125(6):1785-95
references.pmid: 14724831
references.citation: Allergy. 1996 Aug;51(8):556-62
references.pmid: 8874659
references.citation: J Allergy Clin Immunol. 1997 Jan;99(1 Pt 1):94-9
references.pmid: 9003216
references.citation: Adv Exp Med Biol. 1997;412:225-32
references.pmid: 9192018
references.citation: J Allergy Clin Immunol. 1998 Aug;102(2):286-94
references.pmid: 9723674
references.citation: J Pharmacol Exp Ther. 1998 Oct;287(1):128-36
references.pmid: 9765331
references.citation: Gastroenterol Clin North Am. 1999 Jun;28(2):255-81, vii
references.pmid: 10372268
references.citation: J Allergy Clin Immunol. 2004 Apr;113(4):756-63
references.pmid: 15100684
references.citation: Histol Histopathol. 2000 Jul;15(3):899-920
references.pmid: 10963133
references.citation: Am J Pathol. 2001 Feb;158(2):681-90
references.pmid: 11159205
references.citation: Clin Infect Dis. 2001 May 15;32(10):1470-9
references.pmid: 11317249
references.citation: Trends Immunol. 2001 Sep;22(9):497-501
references.pmid: 11525940
references.citation: Otolaryngol Head Neck Surg. 2001 Nov;125(5):483-6
references.pmid: 11700446
references.citation: Am J Rhinol. 2001 Nov-Dec;15(6):417-21
references.pmid: 11777251
references.citation: Curr Allergy Asthma Rep. 2002 May;2(3):252-8
references.pmid: 11918868
references.citation: Int Arch Allergy Immunol. 2002 Feb;127(2):118-22
references.pmid: 11919420